APO RESEARCH · REPORT
Sanger Sequencing Service
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
Product & engineering
Understand the product.
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
Selected research
Industry Growth & Trends
Global Sanger Sequencing Service Industry Growth and Trends Forecast to 2032
Market perspective
DNA sequencing refers to the methods and technologies that used to determine the orders of nucleotide bases in a DNA molecule, namely adenine (A), guanine (G), cytosine (C) and thymine (T). DNA sequencing enables us to perform a thorough analysis of DNA because it provides us with the most basic information of all: the sequence of nucleotides. The knowledge of DNA sequences has formed the basis of basic biological researches and clinical genetic diagnosis. There are also numerous applied technology fields such as biotechnology, forensic science and biological systematics that are heavily dependent on the information generated through DNA sequencing. The rapid speed of sequencing attained with modern DNA sequencing technology has been instrumental in the sequencing of the human genome, in the Human Genome Project. Related projects, often by scientific collaboration across continents, have generated the complete DNA sequences the genomes of many animals, plants, and microorganisms. The Sanger method, also referred to as dideoxynucleotide sequencing or chain termination sequencing, is based on the use of dideoxynucleotide (ddNTP) in addition to the normal nucleotides (dNTP) found in DNA. Dideoxynucleotide are essentially the same as nucleotides except they contain a hydrogen group on the 3’ carbon instead of a hydroxyl group (OH). These modified nucleotides, when integrated into a DNA sequence, prevent the addition of further nucleotides thus stop the elongation of the DNA chain. This occurs because a phosphodiester bond cannot form between the dideoxynucleotide and the next incoming nucleotide, and thus the DNA chain is terminated.
According to APO Research, the global Sanger Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Sanger Sequencing Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Sanger Sequencing Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sanger Sequencing Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sanger Sequencing Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Sanger Sequencing Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Sanger Sequencing Service Market by Company
Source BioScience
GenScript
Thermofisher
Nucleics
GenHunter Corporation
LGC Limited
SciGenom Labs
Fasteris SA
CeMIA SA
Microsynth AG
QuintaraBio
Eurofins
Genewiz
Sanger Sequencing Service Segment by Type
Plasmid DNA
PCR Amplicons
Others
Sanger Sequencing Service Segment by Application
Bioscience Companies
Hospitals
Institutions
Sanger Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sanger Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sanger Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sanger Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Sanger Sequencing Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Plasmid DNA
- PCR Amplicons
- Others
Applications
- Bioscience Companies
- Hospitals
- Institutions
Companies covered
- Source BioScience
- GenScript
- Thermofisher
- Nucleics
- GenHunter Corporation
- LGC Limited
- SciGenom Labs
- Fasteris SA
- CeMIA SA
- Microsynth AG
- QuintaraBio
- Eurofins
- Genewiz
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Sanger Sequencing Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Sanger Sequencing Service Market Size by Region (2021-2032)
- 1.4.1 Global Sanger Sequencing Service Market Size by Region (2021-2026)
- 1.4.2 Global Sanger Sequencing Service Market Size by Region (2027-2032)
- 1.5 Key Regions Sanger Sequencing Service Market Size (2021-2032)
- 1.5.1 North America Sanger Sequencing Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Sanger Sequencing Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Sanger Sequencing Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Sanger Sequencing Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Sanger Sequencing Service Market Size Growth Rate (2021-2032)
2 Sanger Sequencing Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Plasmid DNA
- 2.1.2 PCR Amplicons
- 2.1.3 Others
- 2.2 Global Sanger Sequencing Service Market Size by Type
- 2.2.1 Global Sanger Sequencing Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Sanger Sequencing Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Sanger Sequencing Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Sanger Sequencing Service Market Size by Regions
- 2.3.1 North America Sanger Sequencing Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Sanger Sequencing Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Sanger Sequencing Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Sanger Sequencing Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Sanger Sequencing Service Market Size Breakdown by Type (2021-2026)
3 Sanger Sequencing Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Bioscience Companies
- 3.1.2 Hospitals
- 3.1.3 Institutions
- 3.2 Global Sanger Sequencing Service Market Size by Application
- 3.2.1 Global Sanger Sequencing Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Sanger Sequencing Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Sanger Sequencing Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Sanger Sequencing Service Market Size by Regions
- 3.3.1 North America Sanger Sequencing Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Sanger Sequencing Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Sanger Sequencing Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Sanger Sequencing Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Sanger Sequencing Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Sanger Sequencing Service Industry Trends
- 4.2 Sanger Sequencing Service Industry Drivers
- 4.3 Sanger Sequencing Service Industry Opportunities and Challenges
- 4.4 Sanger Sequencing Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Sanger Sequencing Service Revenue (2021-2026)
- 5.2 Global Sanger Sequencing Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Sanger Sequencing Service Key Company Headquarters & Area Served
- 5.4 Global Sanger Sequencing Service Company, Product Type & Application
- 5.5 Global Sanger Sequencing Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Sanger Sequencing Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Sanger Sequencing Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Sanger Sequencing Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Source BioScience
- 6.1.1 Source BioScience Company Information
- 6.1.2 Source BioScience Business Overview
- 6.1.3 Source BioScience Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Source BioScience Sanger Sequencing Service Product Portfolio
- 6.1.5 Source BioScience Recent Developments
- 6.2 GenScript
- 6.2.1 GenScript Company Information
- 6.2.2 GenScript Business Overview
- 6.2.3 GenScript Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 GenScript Sanger Sequencing Service Product Portfolio
- 6.2.5 GenScript Recent Developments
- 6.3 Thermofisher
- 6.3.1 Thermofisher Company Information
- 6.3.2 Thermofisher Business Overview
- 6.3.3 Thermofisher Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Thermofisher Sanger Sequencing Service Product Portfolio
- 6.3.5 Thermofisher Recent Developments
- 6.4 Nucleics
- 6.4.1 Nucleics Company Information
- 6.4.2 Nucleics Business Overview
- 6.4.3 Nucleics Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Nucleics Sanger Sequencing Service Product Portfolio
- 6.4.5 Nucleics Recent Developments
- 6.5 GenHunter Corporation
- 6.5.1 GenHunter Corporation Company Information
- 6.5.2 GenHunter Corporation Business Overview
- 6.5.3 GenHunter Corporation Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 GenHunter Corporation Sanger Sequencing Service Product Portfolio
- 6.5.5 GenHunter Corporation Recent Developments
- 6.6 LGC Limited
- 6.6.1 LGC Limited Company Information
- 6.6.2 LGC Limited Business Overview
- 6.6.3 LGC Limited Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 LGC Limited Sanger Sequencing Service Product Portfolio
- 6.6.5 LGC Limited Recent Developments
- 6.7 SciGenom Labs
- 6.7.1 SciGenom Labs Company Information
- 6.7.2 SciGenom Labs Business Overview
- 6.7.3 SciGenom Labs Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 SciGenom Labs Sanger Sequencing Service Product Portfolio
- 6.7.5 SciGenom Labs Recent Developments
- 6.8 Fasteris SA
- 6.8.1 Fasteris SA Company Information
- 6.8.2 Fasteris SA Business Overview
- 6.8.3 Fasteris SA Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Fasteris SA Sanger Sequencing Service Product Portfolio
- 6.8.5 Fasteris SA Recent Developments
- 6.9 CeMIA SA
- 6.9.1 CeMIA SA Company Information
- 6.9.2 CeMIA SA Business Overview
- 6.9.3 CeMIA SA Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 CeMIA SA Sanger Sequencing Service Product Portfolio
- 6.9.5 CeMIA SA Recent Developments
- 6.10 Microsynth AG
- 6.10.1 Microsynth AG Company Information
- 6.10.2 Microsynth AG Business Overview
- 6.10.3 Microsynth AG Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Microsynth AG Sanger Sequencing Service Product Portfolio
- 6.10.5 Microsynth AG Recent Developments
- 6.11 QuintaraBio
- 6.11.1 QuintaraBio Company Information
- 6.11.2 QuintaraBio Business Overview
- 6.11.3 QuintaraBio Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 QuintaraBio Sanger Sequencing Service Product Portfolio
- 6.11.5 QuintaraBio Recent Developments
- 6.12 Eurofins
- 6.12.1 Eurofins Company Information
- 6.12.2 Eurofins Business Overview
- 6.12.3 Eurofins Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Eurofins Sanger Sequencing Service Product Portfolio
- 6.12.5 Eurofins Recent Developments
- 6.13 Genewiz
- 6.13.1 Genewiz Company Information
- 6.13.2 Genewiz Business Overview
- 6.13.3 Genewiz Sanger Sequencing Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Genewiz Sanger Sequencing Service Product Portfolio
- 6.13.5 Genewiz Recent Developments
7 North America
- 7.1 North America Sanger Sequencing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Sanger Sequencing Service Market Size by Country (2021-2026)
- 7.3 North America Sanger Sequencing Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Sanger Sequencing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Sanger Sequencing Service Market Size by Country (2021-2026)
- 8.3 Europe Sanger Sequencing Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Sanger Sequencing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Sanger Sequencing Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Sanger Sequencing Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Sanger Sequencing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Sanger Sequencing Service Market Size by Country (2021-2026)
- 10.3 South America Sanger Sequencing Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Sanger Sequencing Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Sanger Sequencing Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Sanger Sequencing Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst